Intelligent Investor

Peptech Limited

By · 21 Feb 2003
By ·
21 Feb 2003
Upsell Banner

Recommendation

Arana Therapeutics Limited - AAH
Current price
$1.40 at 15:56 (02 July 2009)

Price at review
$1.07 at (21 February 2003)
All Prices are in AUD ($)
All hopes of a quick and painless settlement to the dispute with Johnson & Johnson subsidiary Centocor over royalty payments have been lost. Peptech announced that informal talks failed to result in an amicable deal. Centocor advised Peptech that it maintains its position that Remicade does not infringe Peptech's patents in relation to the TNF antibodies. Peptech has in turn instructed its lawyers to start preparing for an initiation of formal dispute resolution procedures attached to the licence agreement. With the prospect of a lengthy legal procedure in the air, STEER CLEAR unless you have stuck with this one through thick and thin, in which case you should probably HOLD FOR THE UPSIDE.
IMPORTANT: Intelligent Investor is published by InvestSMART Financial Services Pty Limited AFSL 226435 (Licensee). Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. InvestSMART Funds Management Limited (RE) is the responsible entity of various managed investment schemes and is a related party of the Licensee. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article. Any such transaction could affect the price of the share. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.
Share this article and show your support

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here